Literature DB >> 21307248

Spinal phosphinositide 3-kinase-Akt-mammalian target of rapamycin signaling cascades in inflammation-induced hyperalgesia.

Qinghao Xu1, Bethany Fitzsimmons, Joanne Steinauer, Audrey O'Neill, Alexandra C Newton, Xiao-Ying Hua, Tony L Yaksh.   

Abstract

Phosphinositide 3-kinase (PI3K), Akt, and their downstream kinase, mammalian target of rapamycin (mTOR), are implicated in neural plasticity. The functional linkages of this signaling cascade in spinal dorsal horn and their role in inflammatory hyperalgesia have not been elucidated. In the present work, we identified the following characteristics of this cascade. (1) Local inflammation led to increase in rat dorsal horn phosphorylation (activation) of Akt (pAkt) and mTOR (pmTOR), as assessed by Western blotting and immunocytochemistry. (2) Increased pAkt and pmTOR were prominent in neurons in laminae I, III, and IV, whereas pmTOR and its downstream targets (pS6, p4EBP) were also observed in glial cells. (3) Intrathecal treatment with inhibitors to PI3K or Akt attenuated Formalin-induced second-phase flinching behavior, as well as carrageenan-induced thermal hyperalgesia and tactile allodynia. (4) Intrathecal rapamycin (an mTORC1 inhibitor) displayed anti-hyperalgesic effect in both inflammatory pain models. Importantly, intrathecal wortmannin at anti-hyperalgesic doses reversed the evoked increase not only in Akt but also in mTORC1 signaling (pS6/p4EBP). (5) pAkt and pmTOR are expressed in neurokinin 1 receptor-positive neurons in laminae I-III after peripheral inflammation. Intrathecal injection of Substance P activated this cascade (increased phosphorylation) and resulted in hyperalgesia, both of which effects were blocked by intrathecal wortmannin and rapamycin. Together, these findings reveal that afferent inputs trigged by peripheral inflammation initiate spinal activation of PI3K-Akt-mTOR signaling pathway, a component of which participates in neuronal circuits of facilitated pain processing.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21307248      PMCID: PMC3097059          DOI: 10.1523/JNEUROSCI.2139-10.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  56 in total

1.  An automated flinch detecting system for use in the formalin nociceptive bioassay.

Authors:  T L Yaksh; G Ozaki; D McCumber; M Rathbun; C Svensson; S Malkmus; M C Yaksh
Journal:  J Appl Physiol (1985)       Date:  2001-06

Review 2.  Analysis of subcellularly localized mRNAs using in situ hybridization, mRNA amplification, and expression profiling.

Authors:  James Eberwine; Brian Belt; Janet Estee Kacharmina; Kevin Miyashiro
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

3.  S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway.

Authors:  Mario Pende; Sung Hee Um; Virginie Mieulet; Melanie Sticker; Valerie L Goss; Jurgen Mestan; Matthias Mueller; Stefano Fumagalli; Sara C Kozma; George Thomas
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

4.  Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation.

Authors:  P W Mantyh; E DeMaster; A Malhotra; J R Ghilardi; S D Rogers; C R Mantyh; H Liu; A I Basbaum; S R Vigna; J E Maggio
Journal:  Science       Date:  1995-06-16       Impact factor: 47.728

5.  Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways.

Authors:  Rie Suzuki; Sara Morcuende; Mark Webber; Stephen P Hunt; Anthony H Dickenson
Journal:  Nat Neurosci       Date:  2002-12       Impact factor: 24.884

6.  Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity.

Authors:  S Puig; L S Sorkin
Journal:  Pain       Date:  1996-02       Impact factor: 6.961

7.  Spinal neurons that possess the substance P receptor are required for the development of central sensitization.

Authors:  Sergey G Khasabov; Scott D Rogers; Joseph R Ghilardi; Christopher M Peters; Patrick W Mantyh; Donald A Simone
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

8.  Chronic catheterization of the spinal subarachnoid space.

Authors:  T L Yaksh; T A Rudy
Journal:  Physiol Behav       Date:  1976-12

9.  Intrathecal substance p-saporin attenuates operant escape from nociceptive thermal stimuli.

Authors:  C J Vierck; R H Kline; R G Wiley
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

10.  Activation of phosphatidylinositol 3-kinase and protein kinase B/Akt in dorsal root ganglia and spinal cord contributes to the neuropathic pain induced by spinal nerve ligation in rats.

Authors:  Ji-Tian Xu; Hui-Yin Tu; Wen-Jun Xin; Xian-Guo Liu; Gui-Hong Zhang; Cai-Hong Zhai
Journal:  Exp Neurol       Date:  2007-06-14       Impact factor: 5.330

View more
  60 in total

Review 1.  Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.

Authors:  Martin S Steinhoff; Bengt von Mentzer; Pierangelo Geppetti; Charalabos Pothoulakis; Nigel W Bunnett
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

Review 2.  Drug repositioning: playing dirty to kill pain.

Authors:  Leandro Francisco Silva Bastos; Márcio Matos Coelho
Journal:  CNS Drugs       Date:  2014-01       Impact factor: 5.749

Review 3.  Mechanisms of acupuncture-electroacupuncture on persistent pain.

Authors:  Ruixin Zhang; Lixing Lao; Ke Ren; Brian M Berman
Journal:  Anesthesiology       Date:  2014-02       Impact factor: 7.892

4.  Effects of intraplantar botulinum toxin-B on carrageenan-induced changes in nociception and spinal phosphorylation of GluA1 and Akt.

Authors:  Shafaq Sikandar; Ynette Gustavsson; Marc J Marino; Anthony H Dickenson; Tony L Yaksh; Linda S Sorkin; Roshni Ramachandran
Journal:  Eur J Neurosci       Date:  2016-05-19       Impact factor: 3.386

5.  mTOR and Erk1/2 Signaling in the Cerebrospinal Fluid-Contacting Nucleus is Involved in Neuropathic Pain.

Authors:  Guangling Li; Xianfu Lu; Suming Zhang; Qiangqiang Zhou; Licai Zhang
Journal:  Neurochem Res       Date:  2015-04-07       Impact factor: 3.996

6.  Sinomenine attenuates chronic inflammatory pain in mice.

Authors:  Shuo Li; Jing Han; Dong-Sheng Wang; Qi Yang; Bin Feng; Wen-Bo Kang; Le Yang; Gang Liu; Ming-Gao Zhao
Journal:  Metab Brain Dis       Date:  2016-09-01       Impact factor: 3.584

7.  Spinal cord NMDA receptor-mediated activation of mammalian target of rapamycin is required for the development and maintenance of bone cancer-induced pain hypersensitivities in rats.

Authors:  Ming-Hung Shih; Sheng-Chin Kao; Wei Wang; Myron Yaster; Yuan-Xiang Tao
Journal:  J Pain       Date:  2012-02-15       Impact factor: 5.820

8.  Up-Regulation of Akt and Nav1.8 in BmK I-Induced Pain.

Authors:  Guokun Zhou; Yunlu Jiao; You Zhou; Shichao Qin; Jie Tao; Feng Jiang; Zhi-Yong Tan; Yong-Hua Ji
Journal:  Neurosci Bull       Date:  2018-03-27       Impact factor: 5.203

9.  Urinary bladder organ hypertrophy is partially regulated by Akt1-mediated protein synthesis pathway.

Authors:  Li-Ya Qiao; Chunmei Xia; Shanwei Shen; Seong Ho Lee; Paul H Ratz; Matthew O Fraser; Amy Miner; John E Speich; Jeffrey J Lysiak; William D Steers
Journal:  Life Sci       Date:  2018-03-21       Impact factor: 5.037

10.  mTOR and its downstream pathway are activated in the dorsal root ganglion and spinal cord after peripheral inflammation, but not after nerve injury.

Authors:  Lingli Liang; Bo Tao; Longchang Fan; Myron Yaster; Yi Zhang; Yuan-Xiang Tao
Journal:  Brain Res       Date:  2013-04-11       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.